Verzenio 150 MG tablet UU 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FQQ7U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,205
Award facts
- Contract value 100% obligated
- $69,205.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $69,205.32 to AmerisourceBergen Drug Corp for the supply of Verzenio 150 mg tablets (14-count units) with a completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement that runs through December 2026 and serves as the comprehensive vehicle for global pharmaceutical support to military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Verzenio, a prescription oncology medication, exemplifies the contractor's role in supporting military medical supply chain requirements through DLA's Pharmaceutical Prime Vendor program, which manages pharmaceutical procurement for military treatment facilities and beneficiaries worldwide.
Quick answers
Who was awarded contract SPE2DR26FQQ7U?
SPE2DR26FQQ7U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FQQ7U worth?
The government has obligated $69,205 on SPE2DR26FQQ7U.
Is contract SPE2DR26FQQ7U an order under another contract?
Yes. SPE2DR26FQQ7U is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ7U competed?
The extent of competition for SPE2DR26FQQ7U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award